Please login to the form below

Not currently logged in
Email:
Password:

clinical trial

This page shows the latest clinical trial news and features for those working in and with pharma, biotech and healthcare.

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3

Roche’s MabThera (rituximab) has outperformed mycophenolate mofetil in a phase 3 pemphigus vulgaris clinical trial. ... The safety data generated over the first 52 weeks of the trial were consistent with the MabThera safety profile seen in other

Latest news

  • Sarepta bounces back with new gene therapy data Sarepta bounces back with new gene therapy data

    However, the company has now scored positive nine-month functional results from a clinical trial of three limb-girdle muscular dystrophy type 2E (LGMD2E) patients treated with its new gene therapy. ... It demonstrated functional improvements at day 270

  • Innate Pharma and AstraZeneca take monalizumab into phase 3 Innate Pharma and AstraZeneca take monalizumab into phase 3

    Innate Pharma’s lead candidate monalizumab – which is licensed by AstraZeneca – is heading for a pivotal phase 3 clinical trial. . ... The trial is set to begin in 2020, depending on regulatory and compliance approvals.

  • Genital herpes vaccine candidate heads for human studies Genital herpes vaccine candidate heads for human studies

    Last year, Vical abandoned its VCL-HB01 candidate for HSV-2 infections after it failed a mid-stage clinical trial. ... So far it doesn’t appear to have had any takers. GlaxoSmithKline, Agenus and Vir Biotech have also abandoned HSV-2 vaccines that had

  • Half of European cancer drug trials ‘biased’, says BMJ Half of European cancer drug trials ‘biased’, says BMJ

    Report says studies exaggerate benefits. A new study on clinical trials that supported European approvals for cancer drugs claims almost half could have been affected by bias that exaggerated their benefits. ... The European Clinical Trials Register (ECTR

  • Gracell reports impressive data with one-day CAR-T for leukaemia Gracell reports impressive data with one-day CAR-T for leukaemia

    The Chinese biotech’s FasT CAR-19 has been tested in a clinical trial in patients with relapsed or refractory B-ALL, with 23 of 24 patients achieving a complete remission ... The CAR-T samples for each of the 26 patients enrolled into its trial were

More from news
Approximately 10 fully matching, plus 1,025 partially matching documents found.

Latest Intelligence

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    Crescendo is on track to begin its first clinical trial next year with its lead candidate CB307 and it also has a pipeline of follow-on, first-in-class T-cell

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Like many of its peers, AstraZeneca now firmly believes in what Reic calls “strictly linking reimbursement to the value and the clinical outcome” of a medicine. ... Having said that, in essence all healthcare systems want the same thing: data that

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... This has repercussions for both clinical trial

  • How can we realise the benefits of patient engagement? How can we realise the benefits of patient engagement?

    We need look no further than the major challenges currently faced by pharma at every stage of the product life cycle: clinical trials are delayed or discontinued because of issues with ... in the clinical trial setting.

  • Real-world studies Real-world studies

    trial recruitment, support regulatory filings, expand patient access and be used for drug safety surveillance. ... One of the most impactful places that RWD can be used to cut time and costs is in enrolment processes which can consume up to 40% of the

More from intelligence
Approximately 1 fully matching, plus 130 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    Hewill oversee the clinical development of F-star’s lead product candidate, FS118, a LAG-3/PD-L1-targeting tetravalent bispecific antibody currently in aphase 1 clinical trial, recruiting the  expansion ... He is an active member of the American

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    He said: “Aelix Therapeutics has reached a crucial milestone by enrolling the first patient in the phase I clinical trial and I’m thrilled to be joining the company at this

  • Belgium's TiGenix appoints Dr Gregory Gordon Belgium's TiGenix appoints Dr Gregory Gordon

    TiGenix has also appointed Annette Valles-Sukkar as associate director, clinical projects, and both she and Dr Gordon will report to the company’s chief medical officer Dr Marie Paule Richard. ... Meanwhile, Valles-Sukkar arrives at TiGenix from

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... Lavino joins the Austrian

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy area expertise includes neurology, psychiatry, gastroenterology, women’s health and rare diseases.

More from appointments
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest from PMHub

  • Havas Lynx Launches Specialist Clinical Trial Recruitment Agency, Havas Lynx Faze

    As the agency’s innovation director, he set up a dedicated clinical trial media team and most recently led investments in patient recruitment focused on digital products and services. ... Evans continued, “The plan for Faze is to change the way our

  • Day in the life of an emotive Art Director

    One of my favourites has to be when we worked on clinical trial branding for one of our clients. ... They asked us to develop the look and feel for the entire company’s clinical trial programme that could work across multiple therapy areas from

  • Innovative pricing and contracting options

    Excellent clinical and financial values are drivers for success in pharma, but without efficient, targeted pricing and contracting schemes, the success of any product is not ensured. ... 6. It has also led to the creation of Pfizer Link, an online

  • Pharma exhibition stand design with added value

    We work in all healthcare areas including ethical pharma, OTC and retail products, primary and secondary care communications, R&D and clinical trial events, nursing and NHS commissioning.

  • Planning a pharma exhibition stand? You must read this!

    We work in all healthcare areas including ethical pharma, OTC and retail products, primary and secondary care communications, R&D and clinical trial events, nursing and NHS commissioning.

More from PMHub
Approximately 1 fully matching, plus 93 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics